Top Markets
#1 OSK OSK +15.26%
#2 TENDIES TENDIES +9.20%
#3 Nesa Nesa +8.52%
#4 HOME HOME +8.29%
#5 UnifAI Network UnifAI Network +7.69%
#6 Cash Cat Cash Cat +7.66%
#7 Tornado Cash Tornado Cash +6.73%
#8 Big Time Big Time +4.36%
#9 Bitway Bitway +4.11%
#10 Biconomy Biconomy +3.98%
Coin of the day
OSK OSK
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Myriad Genetics, Inc. Myriad Genetics, Inc.

Myriad Genetics, Inc.

MYGN
Xếp hạng trong cổ phiếu #16419
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company,... Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
Giá cổ phiếu
$3.12
Đồng bộ lần cuối: 2026-09-01
Vốn hóa thị trường
$294.21M
Thay đổi (1 ngày)
-3.26%
Thay đổi (1 năm)
-54.86%
Quốc gia
US
Giao dịch Myriad Genetics, Inc. (MYGN)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Myriad Genetics, Inc. (MYGN)
Giá đóng cửa cao nhất: $3.12 vào 2026-09-01

Giá đóng cửa thấp nhất: $6.26 vào 1995-10-01
Lịch sử giá cổ phiếu của Myriad Genetics, Inc. từ 1995 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -18.04%
2025 -52.58%
2024 -26.48%
2023 13.37%
2022 -33.36%
2021 39.65%
2020 -28.26%
2019 -13.46%
2018 -10.65%
2017 93.59%
2016 -59.78%
2015 23.94%
2014 43.88%
2013 -11.52%
2012 33.91%
2011 -9.35%
2010 -9.34%
2009 -21.06%
2008 31.47%
2007 54.75%
2006 52.27%
2005 -8.28%
2004 76.12%
2003 -21.79%
2002 -71.64%
2001 -35.93%
2000 374.80%
1999 284.52%
1998 -60.30%
1997 -0.15%
1996 -23.04%
1995 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $600.47 23.17%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $206.90 1.53%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $22.46 43.18%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $324.57 91.67%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $545.33 -14.72%
US